Himalaya's Logo
  Search
  Health Help
 
   
 
Direct from Himalaya online.
 
 
Click to select your location.
 
   
Medicinal Range   Animal Health   Personal Care
   
Abana
Bonnisan
Bonnispaz
Clarina
Confido
Cystone
Diabecon
Diakof
Diarex
Evecare
Gasex
Geriforte
Herbolax
Himcocid
Himcospaz
Himplasia
Koflet
Liv.52
Lukol
Menosan
Mentat
Ophthacare
Picrolax
Pilex
PureHands
Purim
Renalka
Reosto
Rumalaya
Rumalaya forte
Rumalaya gel
Septilin
Serpina
Speman
Styplon
Talekt
Tentex forte
Tentex Royal
V-Gel
Anxocare
Appetonic Vet
Diarex Vet
Digyton
Erina
Galactin Vet
Geriforte Vet
Himfertin Vet
Inflamin Vet
Immunol
Liv.52 Protec (Poultry)
Liv.52 Vet
Scavon
Speman Vet
Speman forte Vet
Tentex forte Vet (Poultry)
Acne-n-Pimple Cream
Anti-dandruff Hair Oil
Anti-dandruff Shampoo
Anti-wrinkle Cream
Baby Cream
Baby Lotion
Baby Powder
Diaper Rash Cream
Hair Loss Cream
Muscle & Joint Rub
Nourishing Baby Oil
Sunscreen Lotion
To view the clinical papers, your system needs the free Adobe Acrobat Reader, version 4 or later.
Click here to download.
 
Total no. of papers:27 - Clinical Papers:17, Experimental Papers:10
(Research papers based on Indications)
Highlighted journal names are international publications
 
Non-insulin-dependent diabetes mellitus (NIDDM/type 2) - as a monotherapy or as an adjuvant to other oral antidiabetic drugs
  1. Evaluation of the clinical efficacy and safety of Diabecon in NIDDM
    Dr. K.R. Kohli1, MD, Dr. Shilin Giri2, MD and Dr. S.A. Kolhapure3*, MD. 1Professor & Head, Dr. Sanjay Tamoli, MD (Scholar), Department of Kayachikitsa and Panchkarma, R.A. Podar Medical College, Worli, Mumbai, India, 2Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore, India, 3Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore, India, The Antiseptic 2004; 101(11), 487.


  2. Evaluation of Diabecon (D-400) as an antidiabetic agent - A double-blind placebo-controlled trial in NIDDM patients with secondary failure to oral drugs
    Mohan, V. Madras Diabetes Research Foundation, Chennai, India, Indian Journal of Clinical Practice (1998): (8), 9, 18.


  3. Diabecon in the treatment of diabetes mellitus
    Seshaiah, V., Balaji, V. and Ramkumar, Department of Medicine, Apollo Hospitals, Madras, Sundaram, A., Department of Medicine, Prof. Ambedkar Institute of Diabetes, Kilpauk Medical College Hospital, Madras and Mitra S.K., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, The Indian Practitioner (1997): (50), 7, 589.


  4. Effect of D-400, an ayurvedic herbal formulation on plasma insulin and C-peptide levels in NIDDM patients
    Maji, D., Consultant Endocrinologist and Diabetologist, J.K. Pai Road, Sahapur, Calcutta and Singh, A.K., IPGE&RA, Calcutta University, West Bengal, The Indian Practitioner (1996): (XLIX), 1, 69.


  5. Effect of D-400, an ayurvedic herbal formulation on experimentally-induced diabetes mellitus
    Mitra, S.K., Gopumadhavan, S. and Muralidhar, T.S., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, Phytotherapy Research (1996): (10), 433.


  6. Effect of a herbomineral preparation D-400 in streptozotocin-induced diabetic rats
    Mitra, S.K., Gopumadhavan, S., Muralidhar, T.S., Anturlikar, S.D. and Sujatha, M.B., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, Journal of Ethnopharmacology (1996): 54, 41.


  7. Interaction of a herbomineral preparation D-400, with oral hypoglycaemic drugs
    Sundaram, R., Venkataranganna, M.V., Gopumadhavan, S. and Mitra, S.K., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, Journal of Ethnopharmacology (1996): 55, 1, 55.


  8. Effect of D-400, a herbal formulation, on blood sugar of normal and alloxan-induced diabetic rats
    Anturlikar, S.D., Gopumadhavan, S., Chauhan, B.L. and Mitra, S.K., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, Indian Journal of Physiology and Pharmacology (1995): (39), 2, 95.


  9. Effect of Diabecon, an ayurvedic herbomineral formulation in non-insulin dependent diabetes mellitus cases
    Ganguly, D., Banerjee T., Department of Medicine, Medical College, Calcutta, Singh, A.K., Institute of Postgraduate Education and Research in Ayurveda, Calcutta, and Mitra S.K., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, The Antiseptic (1995): (92), 12, 460.


  10. Effect of D-400, a herbomineral preparation on lipid profile, glycated haemoglobin and glucose tolerance in streptozotocin-induced diabetes in rats
    Mitra, S.K., Gopumadhavan, S., Muralidhar, T.S., Anturlikar, S.D. and Sujatha, M.B., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, Indian Journal of Experimental Biology (1995): (33), Oct., 798.


  11. Anti-diabetic effect of D-400, an Ayurvedic herbal preparation in non-insulin-dependent diabetes mellitus patients
    Mitra, S.K., Hemavathi, T.S., Mohan, A.R. and Rajesha, R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, The Antiseptic (1995): (92), 9, 342.


  12. Effect of D-400 on blood glucose profile in non-insulin dependent diabetes mellitus patients
    Prasanna, B.M. and Prasanna Kumar, K.M., Department of Endocrinology, M.S. Ramaiah Medical and Teaching Hospital, Bangalore, Karnataka, Hemavathi, T.S., Mitra, S.K., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, The Indian Practitioner (1995): (XIVIII), 6, 547.


  13. Evaluation of D-400 – A herbomineral preparation on patients with diabetes mellitus
    Singh, A.K. and Shaw, B.P., Department of Kayachikitsa, Institute of Postgraduate Education in Ayurveda, Calcutta, West Bengal, The Antiseptic (1995): (92), 7, 263.


  14. Alloxan-induced diabetes in rabbits and effect of a herbal formulation D-400
    Dubey, G.P., Dixit, S.P. and Alok Singh, Department of Basic Principles, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, Indian Journal of Pharmacology (1994): 26, 225.


  15. Evaluation of D-400, an indigenous herbal preparation, in diabetes mellitus
    Dubey, G.P., Aruna Agrawal and Alok Singh, Department of Basic Principles, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, Indian Journal of Internal Medicine (1993): (3), 6, 183.


  16. Efficacy and safety of D-400, a herbal formulation, in diabetic patients
    Yajnik, V.H., Acharya, H.K., Vithlani, M.P. and Yajnik, N.V., Department of Medicine, M.P. Shah Medical College, Jamnagar, Gujarat, The Indian Practitioner (1993): (XLVI), 12, 917.
   
NIDDM with signs and symptoms of hyperlipidemia
  1. Multicentric trial of Diabecon (D-400) – A herbomineral preparation on lipid profile in diabetes mellitus
    Mitra, S.K., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, Seshaiah, V., Apollo Hospital, Madras, Tamil Nadu, Agrawal, J.K., Banaras Hindu University, Banaras, Uttar Pradesh, Maji, D., SSKM Hospital, Calcutta, West Bengal, Yajnik, V.H., Physician, Jamnagar, Uttar Pradesh, Prasanna Kumar, K.M., Department of Endocrinology, M.S. Ramaiah Medical College, Bangalore, Karnataka, and Singh, A.K., Ayurvedic Hospital, Calcutta, West Bengal, International Journal of Diabetes in Developing Countries (1996): (16), 87.


  2. Clinical trial of D-400 - A herbomineral preparation in diabetes mellitus
    Maji, D. and Singh, A.K., Department of Endocrinology and Metabolism, IPGME&R, SSKM Hospital, Calcutta, West Bengal, Journal of Diabetic Association of India (1995): (35), 1, 1.
   
NIDDM with early retinopathy
  1. Effect of Diabecon on sugar-induced lens opacity in organ culture: mechanism of action
    M.S. Moghaddama, P. Anil Kumarb, G. Bhanuprakash Reddyb, V.S. Gholea*
    a Biochemistry Division, Department of Chemistry, University of Pune, Pune 411007, India
    b National Institute of Nutrition, Hyderabad 500007, India. Journal of Ethnopharmacology 97 (2005)


  2. Effect of Diabecon (D-400), an ayurvedic herbomineral formulation on diabetic retinopathy
    Dr.Shri Kant, M.S. (Ophth), F.R.F., Reader, Department of Ophthalmology, Dr. M. Sahu, M.D.(Ay.) Ph.D., Reader & Head, Department of Shalya-Shalakya, and Dr.Sanjeev Sharma, Resident Medical Officer, Department of Shalya-Shalakya , Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Dr. Kala Suhas Kulkarni, Medical Advisor, R&D Center, The Himalaya Drug Company, Makali, Bangalore, India, Indian Journal of Clinical Practice (2002): (12), 9, 49.
 
NIDDM with microalbuminuria
  1. Effect of Diabecon in diabetic patients with microalbuminuria
    Malhotra, A.K., Consultant Physician and Diabetologist, Ram Mahohar Lohia Hospital, New Delhi, The Indian Practitioner (1999): (52), 9, 595.


  2. Efficacy of D-400 in NIDDM patients having microalbuminuria
    Yajnik, V.H., Acharya, H.K. and Yajnik, N.V., Department of Medicine, M.P. Shah Medical College, Jamnagar, Gujarat, The Indian Practitioner (1995): (XLVIII), 9, 851.
   
As an adjuvant in insulin-dependent diabetes mellitus (IDDM/type 1)
  1. Evaluation of clinical efficacy of Diabecon with reference to insulin-levels in diabetic patients
    Prasanna Kumar, K.M. and Mala Dharmalingam, Department of Endocrinology and Metabolism, M.S. Ramaiah Medical College Hospital, M.S.R.I.T. Post, Bangalore, India, Medicine Update (2002): (7), 67.


  2. Effect of D-400, a herbomineral formulation on liver glycogen content and microscopic structure of pancreas and liver in streptozotocin-induced diabetes in rats
    Mitra, S.K., Gopumadhavan, S., Muralidhar, T.S. and Seshadri, S.J. R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, India, Indian Journal of Experimental Biology (1996): (34), October, 964.
   
Miscellaneous
  1. Pharmacokinetic interaction of Diabecon (D-400) with rifampicin and nifedipine
    Mitra, S.K., Sundaram, R., Venkataranganna, M.V. and Gopumadhavan, S. R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, India, European Journal of Drug Metabolism and Pharmacokinetics (1999): (24), 1, 79.


  2. Safety, efficacy and tolerability of D-400, an ayurvedic hypoglycaemic formulation, in healthy male medical students
    Mohan, A.R., Chauhan, B.L., Mitra, S.K. and Kulkarni, R.D., R&D Centre, The Himalaya Drug, Co., Bangalore, Karnataka, Current Medical Practice (1993): (37), 12, 245.


  3. Lack of teratogenicity after administration of D-400, an oral hypoglycemic ayurvedic formulation, during gestation and lactation
    Murlidhar, T.S., Gopumadhavan, S., Chauhan, B.L. and Kulkarni, R.D., R&D Centre, The Himalaya Drug Co., Bangalore, Karnataka, India, Journal of Biological and Chemical Research (1993): (12), 3&4, 151.
     
  FAQs   |   Glossary   |   Sitemap   |   Privacy Policy   |   Terms of Use  
  Copyright © 2002 The Himalaya Drug Company.